Loading...

World-Class Retina Care. Community-Based Caring.

Dr. Abbey Participated in Roundtable Discussion on Newer Therapies for Wet AMD and Diabetic Macular Edema

Posted On October 9, 2024 / By / Posted in Blog

Dr. Abbey Participated in Roundtable Discussion on Newer Therapies for Wet AMD and Diabetic Macular Edema

Texas Retina’s Ashkan Abbey, MD, recently participated in a roundtable discussion on “Navigating Wet AMD and DME Using Newer Therapies” available on Eyetube. Dr. Abbey and fellow panelist Scott Walter, MD, MSc,

read more
Posted On August 29, 2024 / By / Posted in Blog

Offices Closed for Labor Day on 9/2/24

All Texas Retina Associates offices will be closed on Monday, September 2, 2024, in observance of Labor Day. We wish everyone a safe and happy holiday weekend!

read more
Posted On August 15, 2024 / By / Posted in Blog

Dr. Abbey Publishes Case Report on Management of Cystoid Macular Edema in Coats’ Disease

Texas Retina’s Ashkan M. Abbey, MD, recently co-authored a case report in the medical journal Ophthalmic Surgery, Lasers and Imaging Retina (OSLI Retina) on the use of an injectable flucocinolone implant for

read more
Posted On August 13, 2024 / By / Posted in Blog

Can Ozempic Affect Your Eyes or Vision?

Initially approved by the U.S. Food and Drug Administration (FDA) to help control blood sugar and treat type 2 diabetes, semaglutide (brand names Ozempic, Wegovy and Rybelsus) has also emerged as a

read more
Posted On August 6, 2024 / By / Posted in Blog

Recent Study Published in Journal of Clinical Oncology Highlights Importance of Prognostic Biomarker for Uveal Melanoma

The results of the Collaborative Ocular Oncology Study Number 2 (COOG2) were published in the July 2024 issue of the Journal of Clinical Oncology and validated the prognostic accuracy of the integrated

read more
Posted On August 2, 2024 / By / Posted in Blog

Dr. Abbey First in the World to Administer Novel Trispecific Fusion Antibody EB-105 for Diabetic Macular Edema as Part of Phase Ib LOTUS Clinical Trial

On July 9, Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, dosed the first patient in the Phase Ib LOTUS trial of EB-105, the world’s first pentavalent trispecific

read more
Posted On July 17, 2024 / By / Posted in Blog

July is UV Safety Month — Debunking Seven Common Myths About Sunglasses

When most people think of UV protection, they think of their skin and sunscreen. Did you know that long-term exposure to bright sunlight may also increase your risk of eye disease? July

read more
Posted On April 24, 2024 / By / Posted in Blog

Monitoring Age-related Macular Degeneration at Home

As the leading cause of vision loss in older adults, age-related macular degeneration (AMD) is the most common reason patients are referred to Texas Retina. It happens when the central part of

read more
Posted On April 2, 2024 / By / Posted in Blog

Protect Your Eyes as You Enjoy the April 8 Great American Eclipse

On April 8, 2024, North America will witness a rare total solar eclipse as the moon passes between the sun and the Earth, briefly blocking the sun’s rays for several minutes and darkening

read more
Posted On March 29, 2024 / By / Posted in Blog

Honoring Our Physicians

Tomorrow, March 30, is National Doctor’s Day. At Texas Retina, we celebrate all 16 of our physicians as well as all of the physicians who care for our patients and communities. Thank

read more